🧐 At a Glance
Chemkart India, a B2B supplier of health and nutrition ingredients, is raising ₹80 Cr via SME IPO. With 55% revenue growth, 67% PAT growth, and a 20x FY25 EPS valuation, it wants to become the Zerodha of B2B whey. But is it health or hype?
1. 🪝 Introduction with Hook
Your gym bro’s protein shake might have passed through Chemkart’s warehouse. No kidding.
Chemkart India Ltd is a health & food ingredient distributor that’s turned amino acids, whey, herbal extracts and sports nutrition into a ₹300 Cr market cap IPO. But don’t be fooled by the healthy exterior — the valuation has supplements too.
With EBITDA margin at 16%, PAT up 67%, and post-issue P/E at 12.4x, it’s asking for your money… not your BMI.
2. 🧳 Business Model (WTF Do They Even Do?)
Chemkart is like the D-Mart of nutrition ingredients — but for B2B clients:
🧃 Sells raw materials used in health supplements:
- Amino acids
- Proteins
- Herbal extracts
- Vitamins
- Sports nutrition inputs
🏭 Also offers grinding, blending, packaging in-house at a 28,000+ sq. ft. warehouse in Bhiwandi
🎯 Their clients are brands & manufacturers who package the final tablets, powders, or wellness magic you see in stores
It’s a distribution-first, inventory-light, and customer-friendly business — not a flashy D2C wellness startup.
3. 💰 Financials Overview –
